AstraZeneca sees 2022 growth as dividend rises but Covid boost falls
Sales for Covid-19 products expected to decline, profit margins to be lower
Sales for Covid-19 products expected to decline, profit margins to be lower
Study backs up need for booster doses to stop people suffering breakthrough infections
Former French health minister says UK ‘acted sensibly’ by moving early with vaccine boosters
Pharma company to create 100 jobs in Ireland as part of $360m investment
Pharma group agrees to provide remaining doses by March
Belgian judges impose €10 a dose fine on any failure to deliver 50m doses over summer
The drugs company has been in the headlines for all the wrong reasons
Incentive could be worth 250 times his base salary
Europe Letter: Debate in Ireland is divorced from reality of the global scramble for doses
Company has pledged not to profit from vaccine during pandemic
Commission president says contract undermines AstraZeneca position on supplies from UK
Diplomatic spat and last-minute efficacy questions add to uncertainty on jab’s approval
Shares in pharma group slip 2% on news
Europe Letter: The pandemic will not end without international co-operation
Deepening row over vaccines risks bitter EU-UK fallout
EU Commission had earlier said the pharmaceutical company was refusing to attend
EU asks drugmaker if it can divert doses of vaccine from UK to make up for shortfall
Johnson & Johnson vaccine may be game-changer after clumsy missteps by AstraZeneca
Executive says company expects all deliveries to occur as agreed after it warns of delays
Dialysis patient Brian Pinker receives jab as UK rolls out Covid vaccine amid soaring cases
UK order 100 million doses of the vaccine - enough to vaccinate 50 million people
Shares down as much as 9% after weekend announcement
Almost 61 million cases confirmed worldwide as Japan, New York and Germany see rise
Drugmaker wants new test to confirm 90% efficacy rate after uncertainty and confusion
Drug maker AstraZeneca agrees to sell vaccine at cost to developing nations in perpetuity
Researchers say drug companies need to be more open with the public
Pharma industry trying to pull off unprecedented feat
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Deals involving billionaire Bill Gates guarantee early supply to lower-income countries
Drugmaker’s total revenue and earnings fell in the quarter, as analysts had expected
Results from long-awaited Mystic lung cancer study fail to show hoped-for patient recovery
Cantillon: Brexit decision may be giving Big Pharma doubts about British location
Emma Walmsley’s lack of experience cited as justification for salary
Pharmaceutical giant reports 4 per cent fall in revenue to $5.7 billion in third quarter
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices